Dienstag, 7. Mai 2024
Navigation öffnen
Anzeige:
Wefra Programatic
 
JOURNAL ONKOLOGIE – STUDIE
ChangeQoL

Quality of Life and High-Risk Abdominal Cancer Surgery

Rekrutierend

NCT-Nummer:
NCT04444544

Studienbeginn:
September 2020

Letztes Update:
01.03.2023

Wirkstoff:
-

Indikation (Clinical Trials):
Frailty

Geschlecht:
Alle

Altersgruppe:
Erwachsene (18+)

Phase:
-

Sponsor:
University Hospital, Geneva

Collaborator:
-

Kontakt

Studienlocations
(1 von 1)

Studien-Informationen

Brief Summary:

The investigators plan to measure the changes of health-related quality of life (HRQoL) at 6

months and 12 months after the following high-risk oncological abdominal surgery:

gastrectomy, esophagectomy, pancreatectomy and hepatectomy. The investigators will measure

the HRQoL using the validated EORTC QLQ-C30 questionnaire before and at 6 months and 12 month

after the surgery. The investigators will identify phenotypes of HRQoL changes (improvement,

stability and deterioration) at 6 months and 12 months after surgery.

The second aim is to assess the regret of the patient at 6 months and 12 months regarding

his/her decision to undergo surgery. The investigators will also assess the regret of the

next of kin at 6 months regarding the decision to undergo surgery.

This descriptive, prospective, observational, single-centre cohort study aims to: identify

phenotypes of HRQoL changes after abdominal surgical oncology (improvement, stability and

deterioration); assess the regret of patients regarding their decision to undergo surgical

oncology at 6 months and 12 months; assess the regret of the next of kin regarding the

decision of the patient to undergo surgical oncology at 6 months and 12 months. The

investigators will include patients scheduled for the following elective abdominal cancer

surgery: gastrectomy; esophagectomy; pancreas resection and hepatectomy. The investigators

will assess HRQoL using the validated EORTC QLQ-C30 Summary Score before and 6 months and 12

months after surgery. The cut-offs for the three phenotypes of HRQoL changes will be defined

using the minimal clinically important difference (MCID) of 10 points. The investigators will

assess regret using the Decision Regret Scale (DRS) at 6 months and 12 months after surgery.

The expected results are: The investigators can identify phenotypes of HRQoL changes after

surgical oncology using the EORTC QLQ-C30 Summary Score; the investigators will describe the

distribution of these phenotypes and will find an association with the pre-existing frailty.

The investigators can describe the extent of the regret of the patient and of the next of kin

at 6 months using the DRS. The investigators will observe an association between the DRS

score at 6 months and the HRQoL Summary Score change. The investigators will not observe a

relationship between the DRS score of patients and next-of-kins.

Ein-/Ausschlusskriterien

Inclusion Criteria:

- Adult patients (>18 years) scheduled for the following elective abdominal cancer surgery

known for high one-year mortality4: gastrectomy; esophagectomy; pancreas resection and

hepatectomy

Exclusion Criteria:

- Patients with inoperable tumours; i.e. some patients will be excluded at the time of

surgery if unexpected advanced tumour staging is confirmed intraoperatively (e.g.

peritoneal carcinomatosis or any other diagnosis without therapy).

- Hepatectomy for metastasectomy

- Mentally impaired patients (known diagnosis)

- Psychotic diagnoses (i.e. schizophrenia)

- Dementia (mini mental score (MMSE) < 18)

- Incapacity to understand the information sheet

- Blindness (unable to perform the visual part of the mini-mental state examination)

Studien-Rationale

Primary outcome:

1. Health-related Quality of Life (Time Frame - 6 months after surgery):
EORTC-QLQ C30. Minimum 0, Maximum 100



Secondary outcome:

1. Regret (Time Frame - 6 and 12 months after surgery):
Decision Regret Scale. Minimum 0, Maximum 100

2. Health-related Quality of Life (Time Frame - 12 months after surgery):
EORTC-QLQ C30. Minimum 0, Maximum 100

Geprüfte Regime

  • High Risk Abdominal Surgery:
    Pancreatectomy, Esophagectomy, Gastrectomy and Hepatectomy

Quelle: ClinicalTrials.gov


Sie können folgenden Inhalt einem Kollegen empfehlen:

"Quality of Life and High-Risk Abdominal Cancer Surgery"

Bitte tragen Sie auch die Absenderdaten vollständig ein, damit Sie der Empfänger erkennen kann.

Die mit (*) gekennzeichneten Angaben müssen eingetragen werden!

Die Verwendung Ihrer Daten für den Newsletter können Sie jederzeit mit Wirkung für die Zukunft gegenüber der MedtriX GmbH - Geschäftsbereich rs media widersprechen ohne dass Kosten entstehen. Nutzen Sie hierfür etwaige Abmeldelinks im Newsletter oder schreiben Sie eine E-Mail an: rgb-info[at]medtrix.group.